Article - 06/08/2012 VivaCell Biotechnology GmbH investigates the health-promoting effect of food VivaCell Biotechnology GmbH offers in vivo and in vitro demonstration of the efficacy of pharmaceutical and phytopharmaceutical compounds and nutraceuticals. Using its specific in vitro and in vivo models, the company has been able to prove the health-enhancing effect of numerous foods, and is thus an excellent partner in the Bioactive Plant Foods Network.https://www.gesundheitsindustrie-bw.de/en/article/news/vivacell-biotechnology-gmbh-investigates-the-health-promoting-effect-of-food
Article - 06/08/2012 varionostic: specialist in epigenetic analyses Ulm-based varionostic helps epigenetics researchers to obtain information on gene activity. The company is specifically focused on the analysis of methyl groups (-CH3) that are attached to DNA and turn genes on and off. Just as the field of epigenetics, previously only known to insiders, has emerged as a biomedical area of research, the University of Ulm spin-off has matured and grown over the past six years since it was set up.https://www.gesundheitsindustrie-bw.de/en/article/news/varionostic-specialist-in-epigenetic-analyses
Press release - 23/07/2012 ADIRO GmbH presented chromatography learning system at ACHEMA 2012 The new learning system enables schools, higher education institutions and companies to make chromatography and the associated automation of production processes more comprehensible to pupils, students and apprentices. The modular system can be used to model chromatographic processes in detail and simulate different scenarios. The chromatography learning system was developed by ADIRO Automatisierungstechnik GmbH and the Esslingen University of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/adiro-gmbh-presented-chromatography-learning-system-at-achema-2012
Article - 29/05/2012 Isabelle Seemann: DNA as building block for nanostructures Since the emergence of nanotechnology in the 1980s DNA has been used as a construction material in many areas. Wires grids and nanorobots can all be produced from this versatile material. Isabelle Seemann scientist at the University of Konstanz works with a particular DNA constellation known as three-way DNA junction. Seemanns findings are of great importance for different areas of knowledge including the material sciences analytics and…https://www.gesundheitsindustrie-bw.de/en/article/news/isabelle-seemann-dna-as-building-block-for-nanostructures
Press release - 29/03/2012 GATC Biotech’s NightXpress sequencing service goes Europe-wide GATC Biotech, Europe’s leading sequencing provider, now offers its overnight sequencing service NightXpress Europe wide. This unique overnight service has been made possible by the recently opened European Custom Sequencing Centre in Cologne. In Constance, the company’s headquarters, GATC Biotech is building up the European Genome and Diagnostics Centre.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-s-nightxpress-sequencing-service-goes-europe-wide
Dossier - 26/03/2012 Nanobiotechnology The term nanotechnology is known by well over 50 of Germans especially since the lotus effect hit the headlines in the late 1990s. Around the turn of the millennium bio was inserted between nano and technology and nanobiotechnology has since taken up more and more room in the headlines as well as requiring major financial investment. What is nanobiotechnology what is the difference between nanotechnology and nanobiotechnology and where and what…https://www.gesundheitsindustrie-bw.de/en/article/dossier/nanobiotechnology
Article - 19/03/2012 Protein aggregation: when proximity becomes dangerous The aggregation of proteins in the human body might have severe medical consequences, as is the case with Alzheimer’s disease, for example. A less known fact is that the biopharmaceutical industry is also faced with the biological phenomenon of protein aggregation and is working on preventive measures. https://www.gesundheitsindustrie-bw.de/en/article/news/protein-aggregation-when-proximity-becomes-dangerous
Article - 19/03/2012 Goal: online glucose sensor for bioreactors Microorganisms and sensitive cells that are grown in bioreactors need a well-regulated environment and a food supply in order to do what they are supposed to do: grow and produce biomass and metabolites. Many fermenters are equipped with sensors that continuously measure critical bioprocess parameters, including temperature, pH value and oxygen. Online glucose and ethanol sensors are not yet used in regulated bioreactors, even though they would…https://www.gesundheitsindustrie-bw.de/en/article/news/goal-online-glucose-sensor-for-bioreactors
Article - 12/03/2012 Biological nanopores on chips for determining the properties of molecules Researchers led by Prof. Dr. Jan C. Behrends and Dr. Gerhard Baaken from the University of Freiburg have developed a chip the size of a fingertip containing biological nanopores that determine molecule mass with great precision. Developing this new system which is a combination of biological and micro-technical components involved a great deal of technical skill. The system has the same level of sensitivity as a chromatography device but is much…https://www.gesundheitsindustrie-bw.de/en/article/news/biological-nanopores-on-chips-for-determining-the-properties-of-molecules
Article - 09/01/2012 Nutritional medicine: Can certain foods help treat cancer? Researchers at the Centre for Nutritional Medicine (ZEM), a joint institution of the Universities of Hohenheim and Tübingen, are investigating whether and to what extent certain food components can support the treatment of cancer and are hoping to derive scientifically founded dietary recommendations from their findings.https://www.gesundheitsindustrie-bw.de/en/article/news/nutritional-medicine-can-certain-foods-help-treat-cancer
Article - 19/12/2011 New research training group to investigate bacterial survival strategies The University of Tübingen is to establish a new DFG-funded research training group in which doctoral students from twelve research groups will investigate bacterial survival strategies. The results will contribute to the development of new antimicrobial drugs and also be put to good use in the fields of epidemiology and ecology.https://www.gesundheitsindustrie-bw.de/en/article/news/new-research-training-group-to-investigate-bacterial-survival-strategies
Press release - 12/12/2011 Insilico Biotechnology and Metabolomic Discoveries pool their expertise Insilico Biotechnology and Metabolomic Discoveries have agreed to pool their expertise to provide industrial biotech customers with a more comprehensive package of high quality services. The main focus of the cooperation lies in the field of applied systems biotechnology dealing with the metabolism of bacteria, fungi and mammalian cells. The combination of modern analytical methods with high-performance computing will give customers detailed…https://www.gesundheitsindustrie-bw.de/en/article/press-release/insilico-biotechnology-and-metabolomic-discoveries-pool-their-expertise
Article - 12/12/2011 Comprehensive Biomarker Center GmbH – next-generation biomarkers Biomarker research has moved on from proteins to nucleic acids where one of the main priorities is the use of microRNA expression profiles. The Heidelberg-based biotech company Comprehensive Biomarker Center GmbH (CBC, formerly febit) has state-of-the-art technologies and the skills and knowledge to advance the development of new nucleic acid biomarkers for complex diseases in cooperation with partners from research and industry. https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-biomarker-center-gmbh-next-generation-biomarkers
Press release - 28/11/2011 CeCo Labs develops new method for isolating bacterial cell walls CeCo Labs UG, founded as a spin-off from the University of Tübingen, has developed an internationally unique method for isolating bacterial cell walls. These are used in research to investigate antibiotic resistance, for example. Unlike conventional techniques, the method developed by CeCo Labs is able to supply a very high number of ultra-pure cell walls extremely quickly. Orders have already been placed by customers across the globe.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ceco-labs-develops-new-method-for-isolating-bacterial-cell-walls
Press release - 15/11/2011 PANATecs GmbH will move into new laboratories in Heilbronn in 2012 In Summer 2012, PANATecs will move its headquarters to Heilbronn, where the firm will have modern and purpose-built laboratories in the Wohlgelegen Research Park.https://www.gesundheitsindustrie-bw.de/en/article/press-release/panatecs-gmbh-will-move-into-new-laboratories-in-heilbronn-in-2012
Article - 14/11/2011 Does cloudy apple juice prevent colon cancer? The likelihood of developing colon cancer very much depends on dietary factors. Foods and nutrients with antioxidative and anti-inflammatory properties have been found to reduce the likelihood of developing this kind of cancer. Research done by scientists from the Karlsruhe-based Max Rubner-Institut suggests that cloudy apple juice can prevent colon cancer. However, little is yet known about the molecular relationships between diet and disease.https://www.gesundheitsindustrie-bw.de/en/article/news/does-cloudy-apple-juice-prevent-colon-cancer
Dossier - 14/11/2011 The European Nutrition and Health Claims Regulation - an interesting recipe The EU Nutrition and Health Claims Regulation applies to all nutrition and health claims made in commercial communications, including the advertising and labelling of food and promotional campaigns. While the information related to nutrition is now clear, the list of permitted health claims is still under development.https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-european-nutrition-and-health-claims-regulation-an-interesting-recipe
Article - 14/11/2011 BioTeSys GmbH - The basics of substance testing Esslingen-based BioTeSys GmbH is contracted by its clients to determine the bioactive potential of substances and substance mixtures of foods and dietary supplements. Substances are tested whether or not they have a positive effect on human health using a range of chemical analyses, cell-based tests and clinical trials. https://www.gesundheitsindustrie-bw.de/en/article/news/biotesys-gmbh-the-basics-of-substance-testing
Article - 24/10/2011 BioValley Meet & Match Microfluidics, Lab-on-a-chip This year's third Meet & Match took place at the Novotel in Karlsruhe, Germany on October 20, 2011. About 12 presentations were held by representatives from different companies and universities out of the trinational BioValley: Northwest Switzerland, Alsace in France and South Baden in Germany. This Meet & Match meeting has been a great success thanks to interesting talks and a very attentive audience.https://www.gesundheitsindustrie-bw.de/en/article/news/biovalley-meet-match-microfluidics-lab-on-a-chip
Dossier - 05/10/2011 Biosimilars: follow-on biologics of innovator biopharmaceutical products As blockbuster biopharmaceuticals go off patent, biosimilars are increasingly competing with them for a market share. However, the production of biosimilars is rather complex and costly. The approval of biosimilars is also subject to many hurdles. Their introduction to the very expensive biopharmaceuticals market is often associated with marginal price reductions.https://www.gesundheitsindustrie-bw.de/en/article/dossier/biosimilars-follow-on-biologics-of-innovator-biopharmaceutical-products
Press release - 26/09/2011 Unraveling the properties of plant substances Researchers from the Institute of Analytical Chemistry at the Mannheim University of Applied Sciences are focusing on sensors in their effort to increase the yields of bioreactors and reduce the number of animals used for toxicity testing of pharmaceuticals. In addition, the chemists from Mannheim are aiming to investigate the activity of plant substances in the Bioactive Plant Foods Network, a transnational network for the promotion of bioactive…https://www.gesundheitsindustrie-bw.de/en/article/press-release/unraveling-the-properties-of-plant-substances
Article - 19/09/2011 k-labor GmbH – a specialist in material analysis and characterisation k-labor GmbH focuses on the initial inspection of samples for the automotive industry and the testing of a broad range of different materials. k-labor also specialises in environmental simulations and durability testing and offers consulting and the transfer of technologies in the plastics sector. https://www.gesundheitsindustrie-bw.de/en/article/news/k-labor-gmbh-a-specialist-in-material-analysis-and-characterisation
Article - 18/09/2011 BMBF project AllerGen: DNA test to protect consumers against food allergens People who are hypersensitive to a particular food protein can develop an adverse reaction to the smallest amount of the allergenic protein that can range from mild to severe. Although many allergic people are aware of their hypersensitivity to certain food proteins they can have allergic reactions because they are not always aware of the presence of allergenic proteins in certain food products. This is why the reliable sensitive and quantitative…https://www.gesundheitsindustrie-bw.de/en/article/news/bmbf-project-allergen-dna-test-to-protect-consumers-against-food-allergens
Press release - 05/09/2011 Sequenom announces European licensing agreement with GATC daughter LifeCodexx Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it has partnered with LifeCodexx AG, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test…https://www.gesundheitsindustrie-bw.de/en/article/press-release/sequenom-announces-european-licensing-agreement-with-gatc-daughter-lifecodexx
Article - 01/09/2011 Quality by Design – a paradigm change in bioprocess development Bioprocess technology has undergone a fundamental change with regard to the criteria used for validating product quality: around ten years ago, the U.S. Food and Drug Administration (FDA) revised the 1987 process validation guidance and the subsequent establishment of the Process Analytical Technology (PAT) initiative heralded a paradigm change in bioprocess understanding and control. The FDA’s guidance underwent a paradigm shift from what was…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-by-design-a-paradigm-change-in-bioprocess-development